Two-Tier Market? Biotech Group Warns SEC's Trading Revamp Is Bad for Small Companies

Also, lawmaker drops bill to protect brokers from MiFID II; ICI amps up attacks on 'swing pricing'

Lawmakers and business executives often point to the huge drop in the number of initial public offerings as evidence that government red tape has made it difficult for small businesses to raise money, grow and innovate. Now, a trade association representing biotech firms is warning that the regulatory headwinds could get even worse for startups. The cul…